Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Aug 16;14(1):56.
doi: 10.1186/s12954-017-0182-x.

Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy--first long-term case study

Affiliations
Case Reports

Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy--first long-term case study

Samuel S Allemann et al. Harm Reduct J. .

Abstract

Background: Patients with substance use disorders grow older thanks to effective treatments. Together with a high prevalence of comorbidities, psychological problems, and low social support, these patients are at high risk for medication non-adherence. Established treatment facilities face challenges to accommodate these complex patients within their setting. Electronic medication management aids (e-MMAs) might be appropriate to simultaneously monitor and improve adherence for these patients.

Case presentation: We report the first long-term experiences with a novel remote electronic medication supply model for two opioid-dependent patients with HIV. John (beginning dementia, 52 years, 6 tablets daily at 12 am) and Mary (frequent drug holidays, 48 years, 5-6 tablets daily at 8 pm) suffered from disease progression due to non-adherence. We electronically monitored adherence and clinical outcomes during 659 (John) and 953 (Mary) days between July 2013 and April 2016. Both patients retrieved over 90% of the pouches within 75 min of the scheduled time. Technical problems occurred in 4% (John) and 7.2% (Mary) of retrievals, but on-site support was seldom required. Viral loads fell below detection limits during the entire observation period.

Conclusions: Continuous medication supply and persistence with treatment of over 1.7 years, timing adherence of more than 90%, and suppressed HIV viral load are first results supporting the feasibility of the novel supply model for patients on opioid-assisted treatment and polypharmacy.

Keywords: Interprofessional collaboration; Medication adherence; Medication management aid; Old age; Substance use disorders.

PubMed Disclaimer

Conflict of interest statement

Consent for publication

Informed consent was obtained from the patients for the publication of this case study.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Remote-controlled, electronic medication management aid, Medido®, used in this study to dispense the unit-of-dose pouches. Notes: height × width × length, 140 mm × 140 mm × 225 mm. Weight, 1486 g. The inset shows the power cord
Fig. 2
Fig. 2
Unit-of-dose pouches with pre-packed oral solid medication from front (a) and back (b). Note: patient’s name and date of birth were concealed for privacy reasons
Fig. 3
Fig. 3
Novel medication supply model where the community pharmacy provides unit-of-use pouches (medication roll Mo-Su) with all solid oral medications directly to patient home, except opioids for opioid-assisted treatment (OAT) and methylphenidate (S). The pouches are loaded into a lockable, remote-controlled dispenser that can be programmed according to a patient’s medication schedule. The dispenser records dates and times of medication retrievals and wirelessly transmits them to a server (blue waves). Patients obtain the opioid agonist therapy (S) from the outpatient addiction service (OAS) in regular intervals, at least once weekly, according to local law requirements
Fig. 4
Fig. 4
Time of medication dispense for John (659 days) and Mary (953 days) recorded with electronic monitoring. White areas are days with missing electronic monitoring (John, 0.8%; Mary, 4.4% of all days)
Fig. 5
Fig. 5
HIV viral load and CD4 cell count of John and Mary. Start of electronic monitoring is marked with an arrow

References

    1. European Monitoring Centre for Drugs and Drug Addiction . Treatment and care for older drug users. Luxembourg: Publications Office of the European Union; 2010.
    1. Dursteler-MacFarland KM, Vogel M, Wiesbeck GA, Petitjean SA. There is no age limit for methadone: a retrospective cohort study. Subst Abuse Treat Prev Policy. 2011;6:9. doi: 10.1186/1747-597X-6-9. - DOI - PMC - PubMed
    1. Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS. 2008;22:2371–2380. doi: 10.1097/QAD.0b013e328315cdd3. - DOI - PubMed
    1. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705. doi: 10.1111/j.1365-2125.2012.04167.x. - DOI - PMC - PubMed
    1. Oehl M, Hummer M, Fleischhacker W. Compliance with antipsychotic treatment. Acta Psychiatr Scand. 2000;102:83–86. doi: 10.1034/j.1600-0447.2000.00016.x. - DOI - PubMed

Publication types

Substances